Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Access multiple myeloma specialists in Tucson at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
The purpose of this study is to compare the efficacy of teclistamab in combination with daratumumab and lenalidomide (Tec-DR) and talquetamab in combination with daratumumab and lenalidomide (Tal-DR) versus daratumumab, lenalidomide, dexamethasone (DRd).
Sponsor: Janssen Research & Development, LLC
Check if you qualify for this multiple myeloma clinical trial in Tucson, AZ
If you're searching for multiple myeloma treatment options in Tucson, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.